Step by Step

INTRODUCTION

2/6/2025 Anesthesiology Journal Club - Anesthesia, Hormonal Contraception, and Unintended Pregnancy

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Anesthesiologists and anesthesiologists-in-training and other anesthesia professionals, nurse anesthetists and anesthesia assistants.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Review mechanism of action and perioperative uses of sugammadex and aprepitant/fosaprepitant.
  • Recognize impact of sugammadex and aprepitant/fosaprepitant on hormonal contraception.
  • Discuss alternative contraceptive use with patientss recieving ssugammadex and/or aprepitant/fosaprepitant in the periopeerative period.

Joint Accreditation Statement - Note: This Accreditation Statement Supersedes All Other Statements:

Joint Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


The University of Pittsburgh School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Each physician should only claim credit commensurate with the extent of their participation in the activity. 


Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Suggested Additional Reading

  1. Whitney, M, et al. (2025) Anesthesia Providers’ Knowledge of Medication Interference with Hormonal Contraception: A Multisite Survey. Anesthesia & Analgesia. 140(1): 145-154.
  2. Dwan, RL, et al. (2021) Unanticipated consequences of switching to sugammadex: Anesthesia provider survey on the hormonee contraceptive drug interaction. Anesthesia & Analgesia. 133: 958-966
  3. Bailard, N, et al. (2018) Aprepitant and fosaprepitant decrease the effectiveneess of hormonal contraceptives. Br J Clin Pharmacol. 84: 602-603

Authors:
Mark Means, MD — PGY-2 Resident, UPMC Department of Anesthesiology & Perioperative Medicine
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclosed.
Megan Turner, MD — PGY-2 Resident, UPMC Department of Anesthesiology & Perioperative Medicine
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclosed.
Sarah Fribance, MD — PGY-2 Resident, UPMC Department of Anesthesiology & Perioperative Medicine
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclosed.
Stephen McHugh, MD, FASA — Assistant Professor, Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh School of Medicine
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.